应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CLYM CLIMB BIO INC
已收盘 03-28 16:00:00 EDT
1.28
+0.01
+0.79%
盘后
1.28
+0.00
0.00%
16:05 EDT
最高
1.33
最低
1.25
成交量
11.53万
今开
1.28
昨收
1.27
日振幅
6.30%
总市值
8,637万
流通市值
3,908万
总股本
6,748万
成交额
14.79万
换手率
0.38%
流通股本
3,053万
市净率
0.41
ROE
-46.26%
每股收益
-1.53
52周最高
11.55
52周最低
1.20
市盈率
-0.83
股息
0.00
股息收益率
0.00
ROA
-10.30%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Climb Bio, Inc.2024财年第三财季实现净利润-8.90百万美元,同比减少124.18%
市场透视 · 2024-11-19
Climb Bio, Inc.2024财年第三财季实现净利润-8.90百万美元,同比减少124.18%
加载更多
公司概况
公司名称:
CLIMB BIO INC
所属市场:
NASDAQ
上市日期:
2021-08-06
主营业务:
Climb Bio, Inc.于2018年10月18日作为特拉华州公司注册成立。该公司是一家生物技术公司,专注于开发神经元兴奋性障碍的新疗法,以解决精神病学、癫痫、慢性疼痛以及外周和中枢神经系统疾病方面未满足的需求。
发行价格:
12.50
{"stockData":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":1.28,"timestamp":1743192000000,"preClose":1.27,"halted":0,"volume":115261,"hourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.28,"latestTime":"16:05 EDT","volume":10160,"amount":13004.8,"timestamp":1743192310540},"delay":0,"floatShares":30530308,"shares":67475395,"eps":-1.5343,"marketStatus":"已收盘","change":0.01,"latestTime":"03-28 16:00:00 EDT","open":1.28,"high":1.33,"low":1.25,"amount":147882.560107,"amplitude":0.062992,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.5343,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":5,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":1.27,"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.28,"latestTime":"16:05 EDT","volume":10160,"amount":13004.8,"timestamp":1743192310540},"volumeRatio":0.806242},"requestUrl":"/m/hq/s/CLYM","defaultTab":"news","newsList":[{"id":"2484991306","title":"Climb Bio, Inc.2024财年第三财季实现净利润-8.90百万美元,同比减少124.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484991306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484991306?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010429,"startTime":"0","endTime":"0","summary":"11月19日,Climb Bio, Inc.公布财报,公告显示公司2024财年第三财季净利润为-8.90百万美元,同比减少124.18%;其中营业收入为0.00美元,每股基本收益为-0.13美元。从资产负债表来看,Climb Bio, Inc.总负债3.42百万美元,其中短期债务58000.00美元,资产负债比为0.65,流动比率为0.58。机构评级:截至2024年11月19日,当前有2家机构对Climb Bio, Inc.目标价做出预测,其中目标均价为4.50美元,其中最低目标价为4.00美元,最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180146a24562b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180146a24562b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLYM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eliemtx.com","stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.0863},{"period":"3month","weight":-0.3952},{"period":"6month","weight":-0.745},{"period":"1year","weight":-0.5399},{"period":"ytd","weight":-0.2944}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":-0.0457},{"period":"3month","weight":-0.0469},{"period":"6month","weight":-0.0077},{"period":"1year","weight":0.0839},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Climb Bio, Inc.于2018年10月18日作为特拉华州公司注册成立。该公司是一家生物技术公司,专注于开发神经元兴奋性障碍的新疗法,以解决精神病学、癫痫、慢性疼痛以及外周和中枢神经系统疾病方面未满足的需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.044593},{"month":2,"riseRate":0.5,"avgChangeRate":-0.039153},{"month":3,"riseRate":0.25,"avgChangeRate":-0.09367},{"month":4,"riseRate":0.666667,"avgChangeRate":0.348996},{"month":5,"riseRate":0.666667,"avgChangeRate":0.076469},{"month":6,"riseRate":0,"avgChangeRate":-0.110135},{"month":7,"riseRate":0.666667,"avgChangeRate":0.058695},{"month":8,"riseRate":0,"avgChangeRate":-0.068582},{"month":9,"riseRate":0.25,"avgChangeRate":-0.130981},{"month":10,"riseRate":0.25,"avgChangeRate":-0.066822},{"month":11,"riseRate":0,"avgChangeRate":-0.143309},{"month":12,"riseRate":0.5,"avgChangeRate":-0.056887}],"exchange":"NASDAQ","name":"CLIMB BIO INC","nameEN":"CLIMB BIO INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CLIMB BIO INC(CLYM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CLIMB BIO INC(CLYM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CLIMB BIO INC,CLYM,CLIMB BIO INC股票,CLIMB BIO INC股票老虎,CLIMB BIO INC股票老虎国际,CLIMB BIO INC行情,CLIMB BIO INC股票行情,CLIMB BIO INC股价,CLIMB BIO INC股市,CLIMB BIO INC股票价格,CLIMB BIO INC股票交易,CLIMB BIO INC股票购买,CLIMB BIO INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CLIMB BIO INC(CLYM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CLIMB BIO INC(CLYM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}